Guest guest Posted March 1, 2006 Report Share Posted March 1, 2006 The side effects of new drugs are receiving more attention than they deserve, said Eli Lilly & Co. Chief Executive Sidney Taurel on Thursday, unnecessarily delaying the regulatory approval process. Asked in an interview why regulators have slowed down the approval of new drugs, Taurel told Reuters there was too much emphasis on drugs' side effects, as opposed to their benefits. --Reuters Reply with your name and street or po box address for your freecopy of The Holistic Dental Digest PLUS, now in its 27th year and helping people on 5 continents. --What dentists aren't likely to learn in Dental School Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.